UNSPSC 85818832: Transfusion of nonautologous whole blood into central artery, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous whole blood into central artery, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30260H1

UNSPSC 85818832 Transfusion of nonautologous whole blood into central artery, open approach is a Commodity code that shows minimal alignment between its nominal scope and the recent state and local contract opportunities posted under it. The solicitation records reflect procurement of occupational health surveillance, disability medical evaluations, surgical benefit administration, pharmacy benefit management, temporary health professional staffing, and youth detention medical services — none of which involve blood transfusion procedures or vascular intervention. The mismatch suggests either a systematic tagging error in the procurement database or the use of this code as a catch-all placeholder for diverse healthcare service categories that procurement offices have not classified under more precise commodity codes.

The recent opportunities span state departments (Washington State Department of Transportation), county governments (Harris County Juvenile Probation Department, Collier County Board of County Commissioners, Santa Clara County Health System), and municipalities (City of Phoenix, City of Long Beach) across Arizona, California, Florida, Texas, and Washington. Representative recent solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance (RFP20260825, due October 9, 2026), and Collier County's RFP for pharmacy benefit management services (RFP 25-8414, due April 9, 2026). Given the disconnect between the code's clinical procedure name and the actual scope of work being solicited, this code does not represent a viable market segment for blood transfusion services or related clinical interventions; pursuit under this code would require first validating whether the opportunities are misclassified or whether the code itself is being used for administrative purposes unrelated to its stated commodity definition.